The ethical committee of the University of Tampere recently gave a positive statement for the clinical study of WellO2 with patients with chronic obstructive pulmonary symptoms. Patented WellO2 counter pressure steam breathing device was developed by Hapella Oy, Finland. (Photo: Business Wire)